Grifols, S.A belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Grifols, S.A (GRFS) current stock price?
As of the latest data, Grifols, S.A stock price is $8.69, with a previous close of $8.50. Grifols, S.A gained $0.19 in the last trading session, representing a 2.24% increase.
What is Grifols, S.A (GRFS) current market capitalization?
Grifols, S.A market cap is approximately 2.24 billion.
What is Grifols, S.A (GRFS) Earnings Per Share (EPS)?
The trailing EPS is $0.63, and the forward EPS is $1.30.
What is Grifols, S.A (GRFS) Price-to-Earnings (P/E) ratio?
Grifols, S.A current P/E ratio is 13.79, with a forward P/E of 6.67.
What is Grifols, S.A (GRFS) EBITDA?
Grifols, S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 395.71 million.
Does Grifols, S.A (GRFS) pay dividends?
Yes. Grifols, S.A pays other dividends with an annualized yield of 1.99% and an estimated annual payout of $0.17 per share.
How did Grifols, S.A (GRFS) perform in its most recent earnings report?
In the last report (December 31, 2025), Grifols, S.A posted an EPS surprise of 0.8% and a revenue surprise of -73.94%.
When is Grifols, S.A (GRFS) next earnings report?
Grifols, S.A is expected to release its next earnings report on March 31, 2026.
What is Grifols, S.A (GRFS) beta (volatility) score?
Grifols, S.A has a beta of 1.190, meaning its volatility is roughly in line with the market.
